<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02928601</url>
  </required_header>
  <id_info>
    <org_study_id>NAOS1</org_study_id>
    <nct_id>NCT02928601</nct_id>
  </id_info>
  <brief_title>Norepinephrine Consumption After Prophylactic Ondansetron</brief_title>
  <official_title>Does Prophylactic Ondansetron Reduce Norepinephrine Consumption in Patients Undergoing Caesarean Section With Spinal Anesthesia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of prophylactic ondansetron on the incidence of spinal
      hypotension and vasopressor consumption in caesarean section patients using norepinephrine
      treatment. Half of participants receive ondansetron before spinal anesthesia while the other
      half receive saline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spinal hypotension in cesarean section patients can occur vigorously and may lead to
      cardiovascular collapse. If doesn't treated precipitously, It can cause maternal hypotension,
      nausea and vomiting and fetal acidosis. Recently norepinephrine has been proposed for the
      prevention and treatment of spinal hypotension with less tendency to decrease HR and CO. It
      has been reported that ondansetron can be used for prophylaxis and treatment of nausea and
      vomiting, may also reduce the vasopressor requirement in patients undergoing caesarean
      section with spinal anesthesia. The aim of the present study is to assess the effect of
      prophylactic ondansetron on norepinephrine consumption and incidence of spinal hypotension,
      and side effects such as maternal nausea, vomiting and bradycardia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Norepinephrine consumption</measure>
    <time_frame>During the cesarean operation</time_frame>
    <description>Whenever systolic arteriel pressure falls below 100 mmHg or below 20% of the preoperative baseline value in both groups norepinephrine (5 µg) will be administered intravenously and total consumption will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bradicardia</measure>
    <time_frame>During the cesarean operation</time_frame>
    <description>Heart rate lower than 60 beat /min will be treated with iv 0.5 mg of atropine and recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Maternal Hypotension</condition>
  <arm_group>
    <arm_group_label>Ondansetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron</intervention_name>
    <description>After spinal anesthesia, half of the patients will be given intravenous 8 mg ondansetron.</description>
    <arm_group_label>Ondansetron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>After spinal anesthesia, half of the patients will be given intravenous 2 mlt saline.</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I-II patients

          -  Between the ages of 18 and 40 years

          -  Scheduled for elective caesarean section with spinal anesthesia

        Exclusion Criteria:

          -  History of hypertension

          -  History of severe hepato-renal disease,

          -  sensitivity or contraindication to ondansetron,

          -  Drug or alcohol abuse

          -  Contraindication to regional anesthesia.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hakkı Ünlügenç, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Çukurova University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Çukurova University</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Gao L, Zheng G, Han J, Wang Y, Zheng J. Effects of prophylactic ondansetron on spinal anesthesia-induced hypotension: a meta-analysis. Int J Obstet Anesth. 2015 Nov;24(4):335-43. doi: 10.1016/j.ijoa.2015.08.012. Epub 2015 Aug 22.</citation>
    <PMID>26421701</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Q, Zhuo L, Shen MK, Yu YY, Yu JJ, Wang M. Ondansetron preloading with crystalloid infusion reduces maternal hypotension during cesarean delivery. Am J Perinatol. 2014 Nov;31(10):913-22. doi: 10.1055/s-0033-1364189. Epub 2014 Feb 10.</citation>
    <PMID>24515619</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2016</study_first_submitted>
  <study_first_submitted_qc>October 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2016</study_first_posted>
  <last_update_submitted>August 21, 2017</last_update_submitted>
  <last_update_submitted_qc>August 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>Feride Karacaer</investigator_full_name>
    <investigator_title>Specialist doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

